Liu Wen, Jiao Xiang, Thutkawkorapin Jessada, Mahdessian Hovsep, Lindblom Annika
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Oncotarget. 2017 Nov 25;8(66):110300-110310. doi: 10.18632/oncotarget.22687. eCollection 2017 Dec 15.
A germline mutation in cancer predisposing genes is known to increase the risk of more than one tumor type. In order to find loci associated with many types of cancer, a genome-wide association study (GWAS) was conducted, and 3,555 Swedish cancer cases and 15,581 controls were analyzed for 226,883 SNPs. The study used haplotype analysis instead of single SNP analysis in order to find putative founder effects. Haplotype association studies identified seven risk loci associated with cancer risk, on chromosomes 1, 7, 11, 14, 16, 17 and 21. Four of the haplotypes, on chromosomes 7, 14, 16 and 17, were confirmed in Swedish familial cancer cases. It was possible to perform exome sequencing in one patient for each of those four loci. No clear disease-causing exonic mutation was found in any of the four loci. Some of the candidate loci hold several cancer genes, suggesting that the risk associated with one locus could involve more than one gene associated with cancer risk. In summary, this study identified seven novel candidate loci associated with cancer risk. It was also suggested that cancer risk at one locus could depend on multiple contributing risk mutations/genes.
已知癌症易感基因中的种系突变会增加患不止一种肿瘤类型的风险。为了找到与多种癌症类型相关的基因座,开展了一项全基因组关联研究(GWAS),对3555例瑞典癌症病例和15581例对照进行了226883个单核苷酸多态性(SNP)分析。该研究使用单倍型分析而非单个SNP分析,以发现假定的奠基者效应。单倍型关联研究在1号、7号、11号、14号、16号、17号和21号染色体上鉴定出7个与癌症风险相关的风险基因座。其中4个位于7号、14号、16号和17号染色体上的单倍型在瑞典家族性癌症病例中得到了证实。对于这4个基因座中的每一个,都有可能对一名患者进行外显子组测序。在这4个基因座中均未发现明确的致病外显子突变。一些候选基因座包含多个癌症基因,这表明与一个基因座相关的风险可能涉及不止一个与癌症风险相关的基因。总之,本研究鉴定出7个与癌症风险相关的新候选基因座。研究还表明,一个基因座的癌症风险可能取决于多个起作用的风险突变/基因。